NeuroSense Therapeutics Ltd. ( NRSNW) - Key Metrics
NRSNW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | -$0.13 | -$0.07 | -$0.07 |
| 2025Q3 | $0 | -$0.13 | -$0.07 | -$0.07 |
| 2025Q2 | $0 | -$0.09 | $0 | $0 |
| 2025Q1 | $0 | -$0.09 | $0 | $0 |
| 2024Q4 | $0 | -$0.08 | $0 | $0 |
NRSNW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -1.48 |
| 2025Q3 | 0% | -2.40 |
| 2025Q2 | 0% | -5.10 |
| 2025Q1 | 0% | -2.51 |
| 2024Q4 | 0% | -3.61 |
NRSNW
Price: $0.01
52 week price:
Earnings Per Share: -0.94 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3227
Market Capitalization: 986667